AI platform synthesizing multiple qualitative data streams and survey inputs representing semi-structured tracking studies in pharma market research
AI+Technology

Rethinking Tracking Studies: Unlocking the Power of AI with Semi-Structured Qualitative

Stay Informed

Get insights delivered to your inbox

Subscribe to receive the latest research, perspectives, and strategic insights from Shapiro+Raj.

    Traditionally, tracking studies in pharma, such as the well-known ATU (Awareness, Trial, and Usage) surveys, have naturally relied on quantitative methodologies. While quant is seen as the ‘gold-standard’ for tracking it does not come without challenges. Sample sizes are often restricted due to the scarcity of specialized physicians and patients with specific conditions. This scarcity can make it challenging to determine when a change in the data is truly meaningful or merely a ‘bobble’ in the data. Further, the nature of quantitative surveys often fails to capture the nuanced “why” behind observed changes. Together these often mean delays in taking any action as a result.

    At the same time, qualitative tracking can feel like nearly an oxymoron. You simply need numbers to track, right? How else do you avoid subjectivity and truly measure trends and changes. Well, we believe today’s AI fundamentally changes this calculation. We believe by tapping into the power of AI and adopting a different approach to qualitative data collection, we can achieve genuine ‘tracking’ of critical market changes to inform business action.

    The key to unlocking the potential of AI to enable qualitative tracking begins with how we collect the data. While traditional qual follows a loose discussion guide, we envision qualitative tracking to use ‘semi-structured data’. By that we mean, asking the same questions in the same way each time and clearly linking answers to their corresponding questions. While we would leave room for additional probing and exploration as needed, this ‘semi-structured’ approach will be critical in creating the right data-set to unlock the full potential of AI-supported analysis.

    With a semi-structured format, AI can more effectively identify patterns, trends, and anomalies across interviews and time periods. The consistent core questions provide a stable framework for comparison across time periods and groups, while the flexible elements allow for the capture of emerging themes and unexpected insights. This method amplifies AI’s scalability advantages. As the volume of data grows over time, the semi-structured format ensures that new data seamlessly integrates with historical information, allowing for ever-richer longitudinal analysis.

    And while previous ‘text-analytics’ or ‘sentiment trackers’ were often underwhelming; the current AI models are a totally different ballgame. This is not counting key words or assigning sentiment tags to responses. Today’s AI models can effectively decode the context and meaning of responses, while simultaneously putting those responses in context of hundreds or thousands of other responses.

    For example, consider the standard battery of association attributes one encounters in a traditional brand tracker or ATU. Rather than selecting a point on a scale, participants might be asked to select 3-5 that best describe the brand and explain why. We hear their actual thinking on the brand rather than guessing how the interpreted attributes, yet we’ve guided the participant to topics we need their reaction to.

    From this semi-structure, AI can not only track trends in responses but also help us analyze themes in their explanation of why to uncover if there is a brand strength or weakness we might have otherwise missed.

    While this type of qualitative tracking will not be right for every situation, we see several potential advantages:

    • 01

      Increased insight from smaller samples, with reduced bias. A key idea would be to allow for more ‘qualitative’ base sizes. In the past, if we had relied on small sample, open-ended data source for tracking, we would have worried about researcher bias. What do we consider a ‘trend’ or a ‘change’? How much are we relying on the subjective interpretation and memory of the researcher to make these calls? However, AI can help mitigate this concern by seamlessly accounting for all current and past data at once and removing much of the researcher bias in data interpretation. This leads to more objective analysis over time.

    • 02

      Detecting weak signals. AI can identify subtle trends or emerging issues in the responses that might be missed in quantitative surveys or human analysis of qualitative feedback. While the semi-structured approach suggested allows for tracking of issues, allowing AI to look across feedback as well as areas of probing can identify emerging issues that can be further investigated.

    • 03

      Greater flexibility. With traditional quantitative tracking, reporting periods are often quite fixed. For example, reports are prepared every 6 months and report on data in 6-month blocks. However, with rolling qualitative fielding plus AI, we can easily investigate changes at different time horizons – looking back 6 months, 12 months, etc. or looking at trends year over year vs. quarterly all with the change of a prompt. AI can also be trained to proactively monitor for a certain aspect and ‘alert’ when shifts are seen.

    All of this means that brands can more rapidly respond to market events and act with agility. Rather than waiting for quantitative data trends to develop, brands can build forward-looking insights that inspire further investigation and ultimately timely action. Ultimately, we believe pharma tracking studies that are qualitative, built on a foundation of semi-structured data, and powered by AI can provide a significant competitive advantage for pharmaceutical companies.